Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess and compare efficacy (complete response [CR] rate) and overall survival (OS) between SGI-110 and TC (treatment choice) in adults with previously untreated AML who are not considered candidates for intensive remission induction chemotherapy.
Critère d'inclusion
- Acute Myeloid Leukemia (AML)